Join
Live feed
·
INSIDERFilingvia Quantisnow
Titan Pharmaceuticals Inc. logo

Director Ben-Tzvi Avraham returned 3,313 shares to the company, closing all direct ownership in the company (SEC Form 4)

ByQuantisnow·Wall Street's wire, on your screen.
TTNP· Titan Pharmaceuticals Inc.
Health Care
Original source

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track TTNP (Titan Pharmaceuticals Inc.) and more on Quantisnow.